| BioID | bio3542 |
|---|
| Name | DEUCRAVACITINIB |
|---|
| ChEMBL ID | CHEMBL4435170 |
|---|
| Molecular Formula | C20H22N8O3 |
|---|
| Molecular Weight | 425.47 |
|---|
| Molecular Weight (Monoisotopic) | 422.1815 |
|---|
| Type | Small molecule |
|---|
| Max Phase | Phase 4 |
|---|
| Target ID | Tar18 |
|---|
| Target Name | Serine/threonine-protein kinase cot (COT) |
|---|
| Synonyms | BMS-986165|DEUCRAVACITINIB|SOTYKTU |
|---|
| Smiles | [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC |
|---|
| Inchi | InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3 |
|---|
| Inchi Key | BZZKEPGENYLQSC-FIBGUPNXSA-N |
|---|
| Molecular Species | NEUTRAL |
|---|
| Targets | 34.0 |
|---|
| Bioactivities | 190.0 |
|---|
| Np Likeness Score | -1.33 |
|---|
| Records Key | ['11; BMS-986165', 'BMS-986165', 'BMS-986165', 'DEUCRAVACITINIB', 'DEUCRAVACITINIB', '6; BMS-686165', 'DEUCRAVACITINIB', 'EUB0001543a', '4; BMS-98616', 'De', 'EUB0001543a', 'De', '3; BMS-986165', 'EUB0001543a', 'EUB0001543a', 'EUB0001543a', 'EUB0001543a'] |
|---|
| Records Name | ['6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-amino)-N-(methyl-d3)-pyridazine-3-carboxamide', '6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide', '6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide', 'DEUCRAVACITINIB', 'DEUCRAVACITINIB', '6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide', 'DEUCRAVACITINIB', 'BMS 986165', 'Deucravacitinib', 'Deucravacitinib', 'BMS 986165', 'Deucravacitinib', 'Deucravacitinib', 'BMS 986165', 'BMS 986165', 'BMS 986165', 'BMS 986165'] |
|---|
| Withdrawn Flag | False |
|---|
| Orphan | 0 |
|---|
